SK bioscience Co.,Ltd. (302440.KS) KSC
41,300.00
+1000(+2.48%)
Currency In KRW
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 3.77T |
| Enterprise Value | 4.13T |
| P/E Ratio | -38.19 |
| PEG Ratio | 0.05 |
| Price/Sales Ratio | 4.87 |
| Price/Book Ratio | 1.82 |
| Enterprise/Revenue | 5.55 |
| Enterprise/EBITDA | -27.22 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | -0.13 |
| Operating Margin | -0.25 |
Management Effectiveness
| Return On Assets | -0.03 |
| Return On Equity | -0.05 |
Income Statement
| Revenue | 651.37B |
| Revenue/Share | 8,508.47 |
| Gross Profit | 59.49B |
| EBITDA | -60.31B |
| Net Income | -56.17B |
| Diluted EPS | -718.26 |
Balance Sheet
| Total Cash | 890.16B |
| Total Cash/Share | 11,382.07 |
| Total Debt | 538B |
| Total Debt/Equity | 0.3 |
| Current Ratio | 4.04 |
| Book Value Per Share | 25,874.96 |
Price History
| 52-Week Change | -9.43 |
| 52-Week High | 61,300 |
| 52-Week Low | 38,800 |
| Moving Average 50 Days | 42,337 |
| Moving Average 200 Days | 47,776.75 |
Statistics
| Average Volume | 138,862 |
| Shares Outstanding | 78.43M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
